@Rob0000 I agree people looking to invest should consider that EQR have two mines currently making no profit but close to break even. They should be on the cusp of making profits with Saloro increasing recoveries repeatedly to the point it was cash flow positive operationally last quarter and soon to start putting cash in the bank. Mt Carbine has not been performing great. But that should change soon with the high grade ore now being processed. Given the market cap of the company this could be a great time to dip the toes in for new investors.
What deposit are they paying upkeep on? It’s not like Almonty with a process plant that was planned to be put into use 2 years ago which they are maintaining in the hope of??? I assume you are referring to Wolfram camp which was granted to them from the QLD government and they have started exploration and are about to start XRT sorter trials with another grant in conjunction with QUT. EQR is just at the beginning of the journey with this one but they could move fast if they get further grants and using their experience from My Carbine. Again potential investors should take note of wolfram camp. Hopefully some initial drill results are not to far away. It is probably worth noting Almonty spent 10s of millions on it just to throw it away as they could not cut the mustard there so there is risk.
I am surprised you didn’t think it was worth mentioning the Ferrotungsten plant potentially being brought on to the EQR books. I think new investors would like to know about that.
Think you had your sentiment wrong, you had it sell not buy mate.
- Forums
- ASX - By Stock
- EQR
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
EQR
eq resources limited
Add to My Watchlist
10.8%
!
4.1¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-216
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.1¢ |
Change
0.004(10.8%) |
Mkt cap ! $111.8M |
Open | High | Low | Value | Volume |
4.0¢ | 4.2¢ | 3.7¢ | $306.8K | 7.833M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 78945 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 349999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 78945 | 0.038 |
1 | 4000 | 0.037 |
1 | 75000 | 0.035 |
3 | 165000 | 0.034 |
3 | 369581 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 349999 | 1 |
0.043 | 88255 | 2 |
0.044 | 575714 | 3 |
0.045 | 1268034 | 2 |
0.046 | 370000 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
EQR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online